978 results on '"Khera, Nandita"'
Search Results
52. Impact of Chronic Graft-versus-Host Disease on Patient Employment, Income, and Informal Caregiver Burden: Findings From the Living With Chronic GVHD Patient Survey
53. Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma
54. Relationship between paid leave, financial burden, and patient-reported outcomes among employed patients who have undergone bone marrow transplantation
55. Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplantation Survivors
56. Navigating Ethical Practices in the Era of High Cost Hematology
57. Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries
58. How to Sequence Therapies in Mycosis Fungoides
59. Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH‐based algorithm distinguishes prognostic groups and outcomes
60. Feasibility and Acceptability of a 3-Day Group-Based Digital Storytelling Workshop among Caregivers of Allogeneic Hematopoietic Cell Transplantation Patients: A Mixed-Methods Approach
61. Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A Center for International Blood and Marrow Transplant Research Analysis
62. TP53 variant allele frequency and therapy‐related setting independently predict survival in myelodysplastic syndromes with del(5q).
63. Financial hardship for patients with cancer and caregivers at end of life in the USA: narrative review.
64. Care utilization and satisfaction among patients with cancer with neutropenic fever managed by a remote patient monitoring (RPM) program.
65. Health insurance literacy among patients receiving outpatient cancer treatment.
66. Allogeneic hematopoietic stem cell transplantation in adults with dendritic/histiocytic neoplasms
67. Patient- and Provider-Level Factors Associated With Telehealth Utilization Across a Multisite, Multiregional Cancer Practice From 2019 to 2021
68. Graft-Versus-Host Disease and Quality of Life: Can We Make a Difference?
69. Health-Related Quality of Life in Young Adult Survivors of Hematopoietic Cell Transplantation
70. Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma
71. Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis
72. Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions
73. Steroid Refractory Chronic Graft-Versus-Host Disease: Cost-Effectiveness Analysis
74. Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation
75. Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia
76. Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis
77. Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes
78. Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis
79. P561: REVUMENIB IN PATIENTS WITH ACUTE LEUKEMIAS: COMPASSIONATE USE PROGRAM EXPERIENCE
80. Conjunctival subepithelial fibrosis and meibomian gland atrophy in ocular graft-versus-host disease
81. Challenges around Access to and Cost of Life-Saving Medications after Allogeneic Hematopoietic Cell Transplantation for Medicare Patients
82. Cytogenetic Evolution in Myeloid Neoplasms at Relapse after Allogeneic Hematopoietic Cell Transplantation: Association with Previous Chemotherapy and Effect on Survival
83. Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis
84. Mast cell cytomorphology and treatment outcome in mast cell leukemia.
85. Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome.
86. Living with Cancer: an Educational Intervention in Cancer Patients Can Improve Patient-Reported Knowledge Deficit
87. The Effect of Psychosocial Interventions on Outcomes for Caregivers of Hematopoietic Cell Transplant Patients
88. Value-Based Care in Hematopoietic Cell Transplantation and Cellular Therapy: Challenges and Opportunities
89. Payment and Coverage Parity for Virtual Care and In-Person Care: How Do We Get There?
90. supplemental figure legend from A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation
91. Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors
92. Practice Patterns and Preferences Among Hematopoietic Cell Transplantation Clinicians
93. Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation
94. Association of Distance from Transplantation Center and Place of Residence on Outcomes after Allogeneic Hematopoietic Cell Transplantation
95. Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions
96. Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
97. Analysis of Medicare Expenditure for Discarded Infused Cancer Therapeutics From 2017-2020
98. Relationships Among Health Insurance Literacy, Financial Toxicity, and Sociodemographic Factors in Patients With Cancer.
99. TP53mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo‐Moffitt study of 156 informative cases
100. Trial in Progress: A Prospective, Observational Cohort Study of Patients at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.